Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

Journal: Science

Published: 2020-09-04

DOI: 10.1126/science.abc8511

Affiliations: 15

Authors: 39

Go to article
Institutions Share
University of Pennsylvania (Penn), United States of America (USA) 0.75
University of Pennsylvania Health System (UPHS), United States of America (USA) 0.09
Penn-CHOP Lung Biology Institute, United States of America (USA) 0.08
Parker Institute for Cancer Immunotherapy, United States of America (USA) 0.04
Thomas Jefferson University (TJU), United States of America (USA) 0.03
Children's Hospital of Philadelphia (CHOP), United States of America (USA) 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER